GB Sciences, Inc.
GBLX · OTC
3/31/2024 | 3/31/2023 | 3/31/2022 | 3/31/2021 | |
|---|---|---|---|---|
| Market Cap | $2,579 | $6,439 | $8,925 | $17,682 |
| - Cash | $12 | $110 | $234 | $793 |
| + Debt | $1,759 | $1,396 | $1,385 | $4,457 |
| Enterprise Value | $4,326 | $7,725 | $10,076 | $21,346 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$1 | -$62 | -$70 | -$47 |
| % Margin | – | – | – | – |
| EBITDA | -$1,420 | -$1,611 | -$1,799 | -$2,000 |
| % Margin | – | – | – | – |
| Net Income | -$1,362 | -$4,125 | -$531 | -$3,725 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.004 | -0.012 | -0.002 | -0.012 |
| % Growth | 64.3% | -576.5% | 85.5% | – |
| Operating Cash Flow | -$976 | -$1,527 | -$1,866 | -$2,185 |
| Capital Expenditures | $0 | -$32 | -$200 | -$293 |
| Free Cash Flow | -$976 | -$1,559 | -$2,066 | -$2,478 |